Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Industrial Organica SA De Cv operates within the Biotechnology & Pharmaceuticals technology area with a portfolio currently showing 1 pending office action. The prosecution activity is confined to 1 distinct art unit. This structure suggests a specialized filing strategy targeting a specific niche within the broader biotechnology sector. By maintaining active prosecution within a single art unit, the company ensures that its technical disclosures are reviewed by a consistent group of specialists at the patent office.
The portfolio involves 1 distinct examiner, SAEED, ALI S, who serves as the busiest examiner. This individual is currently handling 1 busiest examiner pending office action. The presence of only 1 distinct examiner across the portfolio ensures that active prosecution is centralized under a single point of review. This centralization allows for a focused prosecution strategy, as the applicant addresses the specific concerns and preferences of SAEED, ALI S. The company's current patent prospects are subject to the discretion of this one examiner without varied perspectives from different art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 31.3% | +35.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17377092 | Carotenoid Formulation For Increased Bioavailability | SAEED, ALI S | 31d overdue |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17377092 | Carotenoid Formulation For Increased Bioavailability | SAEED, ALI S | 1616 | §103 | Final Rejection | 31d overdue | Pending | Jul 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial